Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
NKTR
#1941
Nektar Therapeutics
73.250
0
USD
+4.11%
Settore:
Salute
Base:
USD
Valuta di Profitto:
USD
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
+4.11%
Variazione Mensile
-0.03%
Variazione di 6 mesi
-0.03%
Variazione Annuale
-0.03%
Chiusura Precedente
70.360
0
Open
73.250
0
Bid
73.250
0
Ask
73.253
0
Low
73.250
0
High
73.250
0
Volume
66
Mercati
Mercato Azionario Statunitense
Salute
NKTR
Open full chart
Financials
Overview
Estratto Conto
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
12.15 M
12.42 M
12.62 M
12.24 M
12.41 M
—
Valuation ratios
Enterprise value
—
—
—
—
—
—
Price to earnings ratio
—
—
—
—
—
—
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
—
—
—
—
—
—
Price to book ratio
—
—
—
—
—
—
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.29
0.47
0.52
0.69
0.39
0.49
Return on equity %
0.41
0.77
1
2.11
1.96
5.72
Return on invested capital %
254.72
426.37
531.3
747.1
563.62
829.6
Gross margin %
87.26
75.57
76.5
62.53
68.82
372.66
Operating margin %
278
437.76
408.63
292.59
106.88
969.43
EBITDA margin %
17.71
-46.1
-160.53
-202.78
-17.91
-1 441.57
Net margin %
290.65
514.03
399.98
306.31
120.86
1 135.04
Liquidity ratios
Quick ratio
9.7
9.15
7.72
6.14
4.26
—
Current ratio
9.83
9.34
8
6.45
4.26
14.35
Inventory turnover
1.39
1.6
1.24
1.91
3.81
—
Asset turnover
0.09
0.08
0.1
0.16
0.28
0.23
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0
—
—
—
—
—
Long term debt to total equity ratio
0
—
—
—
—
—
Per share metrics
Operating cash flow per share
26.31
33.77
24.37
15.21
12.82
12.68
EBIT per share
1.22
-4.91
-12.82
-14.98
-1.58
-12.37
EBITDA per share
2.27
-3.84
-11.84
-14.43
-1.29
-12.03
Total debt per share
—
—
—
—
—
—
Cash per share
89.19
60.06
40.48
23.97
18.62
60.91
Net current asset value per share
95.59
65.11
43.76
26.11
19.06
63.5
Tangible book value per share
84.06
49.35
23.26
10.34
4.43
11.62
Working capital per share
85.86
58.13
38.3
22.06
14.58
45.41
Book value per share
90.49
55.61
29.39
10.34
4.43
11.62
Notizie
Oppenheimer alza il target di prezzo di Nektar Therapeutics a 140$
Oppenheimer raises Nektar Therapeutics price target to $140
Le azioni di Nektar Therapeutics raggiungono il massimo di 52 settimane a 76,3 USD
Nektar Therapeutics stock hits 52-week high at 76.3 USD
Nektar Therapeutics: Q4 2025 mostra aumento di liquidità ed espansione R&D
Earnings call transcript: Nektar Therapeutics Q4 2025 shows cash boost and R&D expansion
Nektar Therapeutics (NKTR) Reports Q4 Loss, Tops Revenue Estimates
Esperion Therapeutics (ESPR) Misses Q4 Earnings Estimates
Analysts Estimate Nektar Therapeutics (NKTR) to Report a Decline in Earnings: What to Look Out for
Wall Street Analysts Think Nektar (NKTR) Could Surge 89.8%: Read This Before Placing a Bet
Nektar Therapeutics stock hits 52-week high at 75.19 USD
Nektar Therapeutics chiude un’offerta pubblica da 460 milioni di dollari